Medical Article

Continuous Glucose Monitoring tools are revolutionizing the way diabetes is managed, offering unparalleled benefits for both healthcare providers and patients. By providing continuous, accurate data, CGM is especially useful for remote monitoring, enabling timely interventions and leading to better user health. The post Improved Access to CGM Data Empowers Providers and Patients to More Effectively…

In two letters, U.S. representatives and senators called for an extension of the enhanced premium tax credits, which are set to expire in 2025 and have lowered costs for those purchasing coverage on the marketplace. The post 195 Congress Members Call for Extension of Enhanced Premium Tax Credits appeared first on MedCity News.

While the policy changes create new opportunities, they also introduce operational complexity. Here’s some important things to know. The post Expanding the Reach of Remote Patient Monitoring: The Real Signal Behind the 2026 RPM Changes appeared first on MedCity News.

Johnson & Johnson stopped short of implementing its proposal to alter the way two drugs are paid for under the 340B drug discount program, but the drugmaker made it clear it still wants changes. In other recent regulatory news, we have drug approvals, clinical holds, and one product withdrawal. The post J&J Backs Down From…